Summer Street Research Partners Closes Second Financing Deal for HeartWare, Ltd.
Advertisement
BOSTON, Aug. 7 Summer Street Research Partners, ahealthcare-dedicated investment firm, is pleased to announce the recentclosing of a financing for HeartWare, Ltd., a company developing ventricularassist devices. HeartWare, a publicly traded company on the Australian StockExchange (HTW), raised A$31 million and Summer Street Research Partners servedas co-U.S. placement agent. This is the second financing for HeartWare closedby Summer Street Research Partners in the past 12 months. Al Sollami, ChiefExecutive Officer of Summer Street Research Partners, commented, "Our twoclosed financings for HeartWare, Ltd in difficult market environments evidenceare success in raising funds for high quality medical companies worldwide.Common shares were placed amongst large well respected U.S. funds and we aredelighted to list HeartWare, Ltd. as one of our clients."Contact: Robert M. Goldman, CFA Senior Managing Director and Head of Investment Banking Summer Street Research Partners 617-532-6409 [email protected]
